Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
We offer a range of medically guided weight loss treatments designed to support different needs and goals
Because as of early 2025, semaglutide and tirzepatide were being removed from the shortage list, they are no longer legally available to be compounded
$23.99 or $20.39/mo Saw Palmetto Extract with Pumpkin Seed Oil* Saw Palmetto Extract plus Pumpkin Seed Oil $31.97 or $27.17/mo
Food and Drug Administration (FDA) on the 1st approved 'Foundayo (ingredient name: orforglipron),' an oral obesity treatment developed by Eli Lilly, the company that supplies the obesity drug 'Mounjaro.' This is the second oral GLP-1 class obesity treatment to be approved, following the pill form of Novo Nordisk's 'Wegovy' last December
